Skip to main content

Table 1 Characteristics of AD and non-AD cohorts

From: The effect of comorbidities on survival in persons with Alzheimer’s disease: a matched cohort study

Characteristic

AD Cohort

N = 70,718

non-AD Cohort

N = 70,718

P-value

Sociodemographic factors

 Age at beginning of follow-up, mean (SD)

80.05 (7.1)

80.02 (7.1)

matched

Categorized age at beginning of follow-up

0.429

  < 80 y

31,971 (45.21)

32,119 (45.42)

 

  ≥ 80 y

38,747 (54.79)

38,599 (54.58)

 

Sex

matched

 Women

46,116 (65.21)

46,116 (65.21)

 

 Men

24,602 (34.79)

24,602 (34.79)

 

Highest occupational social class

< 0.001

 Managerial/ professional

14,692 (20.78)

14,929 (21.11)

 

 Office worker

5973 (8.45)

5888 (8.33)

 

 Farming/forestry

13,439 (19.00)

13,990 (19.78)

 

 Sales/industry/cleaning

30,148 (42.63)

27,748 (39.24)

 

 Unknown/did not respond

6466 (9.14)

8163 (11.54)

 

Comorbidities

 Any cardiovascular disease

35,026 (49.53)

34,757 (49.15)

0.153

 Coronary artery disease

21,668 (30.64)

20,006 (28.29)

< 0.001

 Stroke

6825 (9.65)

5833 (8.25)

< 0.001

 Diabetes

13,714 (19.39)

8081 (11.43)

< 0.001

 Asthma/COPD

7557 (10.69)

7646 (10.81)

0.445

 History of hip fracture

3709 (5.24)

2561 (3.62)

< 0.001

 Cancer treatment within 5 years of start of follow-up

16,200 (22.91)

12,916 (18.26)

< 0.001

 Any mental or behavioral disorder (exc. dementia)

41,106 (58.13)

36,997 (52.32)

< 0.001

Follow-up

 Duration of follow-up days, mean (min.-max.)

1787 (7–4016)

2038 (4–4016)

< 0.001

 Died during follow-up

44,585 (63.05)

26,410 (37.35)

< 0.001

 Died during 4-y follow-up

24,277 (34.33)

15,685 (22.18)

< 0.001

  1. Data are given as n (%) unless otherwise indicated.
  2. Abbreviations: AD, Alzheimer’s disease; COPD, chronic obstructive pulmonary disease; exc., excluding; max., maximum; min., minimum; SD, standard deviation; y, years